# Controlling Rapid Atrial Fibrillation With Dexmedetomidine

> **NCT04042727** · PHASE2,PHASE3 · TERMINATED · sponsor: **Stony Brook University** · enrollment: 13 (actual)

## Conditions studied

- Rapid Atrial Fibrillation
- Heart Rate Control

## Interventions

- **DRUG:** Dexmedetomidine Hydrochloride
- **OTHER:** Normal Saline

## Key facts

- **NCT ID:** NCT04042727
- **Lead sponsor:** Stony Brook University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-08-21
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Futility, as a result of COVID-19 impact
- **Last updated:** 2024-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04042727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04042727, "Controlling Rapid Atrial Fibrillation With Dexmedetomidine". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04042727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*